(Photo by Andrew Zaleski, file)
The mobile health platform is already being used in three separate pilot programs to allow physicians and clinicians based at health organizations to monitor patients’ symptoms, recovery and rehabilitation from a variety of diseases via smartphone.
Invented by medical experts at the Johns Hopkins University in 2008, the emocha mobile platform is HIPAA-compliant and is able to capture data from patients suffering from 10 different diseases, including tuberculosis and multidrug-resistant tuberculosis.
As emocha CEO Sebastian Seiguer explained at Demo Day, emocha will soon be in use by the state government of South Africa in that country’s efforts against multidrug-resistant tuberculosis:
- More than 10,000 healthcare workers and 2,500 primary care clinics in South Africa will be equipped with the emocha platform.
- The goal, as Seiguer explained, is to use emocha so that notifications and alerts are sent to tracing teams in South Africa chasing down outbreaks of multidrug-resistant tuberculosis, as well as to patients and clinics, so that people diagnosed with the disease will be able to start receiving care at clinics within five days of the initial diagnosis.
Investment gives Vista Equity Partners majority stake in Maryland’s Sonatype
5 questions with Myra Norton: How transparent leadership empowers teams to grow and scale
Cybersecurity startup Code Dx wins $2M seed investment at DataTribe Challenge
How this lawyer is helping entrepreneurs bark up the right tree
These 8 ventures are entering Loyola’s first Baltipreneurs accelerator
Between Two Founders: Renalert talks scale after Beta City win
Galen Robotics investment shows how the Opportunity Zone program can fund startups
Get to know SmartLogic’s culture of plants, podcasts and productive client relationships
Sign-up for daily news updates from Technical.ly Baltimore